Healthcare >> CEO Interviews >> October 1, 2001
DR. ROY C. LEVITT was appointed President and CEO in November 2000. He
served as Executive Vice President of the company and led the Magainin
Institute of Molecular Medicine, an internal division of the company,
since joining the company in January 1996. Dr. Levitt also leads the
Research and Development group of the company and was elected director
of the company in August 1997. He was appointed Chief Operating Officer
of the company in August 1998. Prior to joining Genaera, Dr. Levitt was
a faculty member at Johns Hopkins University in the Department of
Anesthesiology and Critical Care Medicine from 1986 to 1995, in
Neurological Surgery from 1995 to 1996 and in Environmental Health
Sciences from 1988 to 1996. He earned his MD at the University of
Maryland School of Medicine in 1979, and he is Board Certified in
Internal Medicine and Anesthesia and Critical Care Medicine. He joined
the Johns Hopkins Department of Internal Medicine in 1980 and eventually
becoming the Chief Resident of the Anesthesiology Department in 1985. Profile
Corporation?
Dr. Levitt: Genaera is a development stage biopharmaceutical company. We
were founded in the late 1980s and
